dihydrotetrabenazine has been researched along with Lewy Body Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, KA; Gilman, S; Junck, L; Koeppe, RA; Wernette, K | 1 |
| An, H; Gilman, S; Giordani, B; Heumann, M; Junck, L; Koeppe, RA; Little, R; Persad, C; Wernette, K | 1 |
| Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S | 1 |
3 other study(ies) available for dihydrotetrabenazine and Lewy Body Disease
| Article | Year |
|---|---|
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine | 2008 |
Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Binding Sites; Biogenic Monoamines; Carbon Isotopes; Corpus Striatum; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed | 2004 |
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine | 2005 |